Trial
NCT02868632
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
AstraZeneca
Condition
Pancreatic Cancer
Intervention
MEDI4736
Why stopped
termination because of low accrual; four subjects enrolled and four screen failures.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-05